Haemonetics Corp. (HAE)
Haemonetics Market Cap : 2.737B for April 9, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Boston Scientific Corp. | 91.10B |
| Edwards Lifesciences Corp. | 46.20B |
| QuidelOrtho Corp. | 976.29M |
| Stryker Corp. | 129.14B |
| Zimmer Biomet Holdings, Inc. | 18.26B |
Market Cap Related Metrics
| PE Ratio | 16.18 |
| PS Ratio | 2.149 |
| PEG Ratio | 0.3742 |
| Price to Book Value | 3.002 |
| Price to Free Cash Flow | 9.195 |
| Price | 58.90 |
| Earnings Yield | 6.18% |
| PEGY Ratio | 0.3742 |
| Operating PE Ratio | 11.64 |
| Normalized PE Ratio | 16.14 |